International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(10), P. 5404 - 5404
Published: May 12, 2022
Alzheimer's
disease
(AD)
constitutes
the
most
prominent
form
of
dementia
among
elderly
individuals
worldwide.
Disease
modeling
using
murine
transgenic
mice
was
first
initiated
thanks
to
discovery
heritable
mutations
in
amyloid
precursor
protein
(APP)
and
presenilins
(PS)
genes.
However,
due
repeated
failure
translational
applications
from
animal
models
human
patients,
along
with
recent
advances
genetic
susceptibility
our
current
understanding
on
biology,
these
have
evolved
over
time
an
attempt
better
reproduce
complexity
this
devastating
improve
their
applicability.
In
review,
we
provide
a
comprehensive
overview
about
major
pathological
elements
AD
(plaques,
tauopathy,
synaptic
damage,
neuronal
death,
neuroinflammation
glial
dysfunction),
discussing
knowledge
that
available
mouse
provided
mechanisms
underlying
disease.
Moreover,
highlight
pros
cons
models,
revolution
offered
by
concomitant
use
omics
technologies
may
lead
more
rapid
improvement
present
battery.
Cell Reports,
Journal Year:
2020,
Volume and Issue:
32(2), P. 107908 - 107908
Published: July 1, 2020
We
present
a
consensus
atlas
of
the
human
brain
transcriptome
in
Alzheimer's
disease
(AD),
based
on
meta-analysis
differential
gene
expression
2,114
postmortem
samples.
discover
30
coexpression
modules
from
seven
regions
as
major
source
AD
transcriptional
perturbations.
next
examine
overlap
with
251
differentially
expressed
sets
mouse
models
and
other
neurodegenerative
disorders.
Human-mouse
overlaps
highlight
responses
to
amyloid
versus
tau
pathology
reveal
age-
sex-dependent
signatures
for
progression.
Human
enriched
neuronal
and/or
microglial
genes
broadly
AD,
Huntington's
disease,
amyotrophic
lateral
sclerosis,
aging.
Other
modules,
including
those
implicated
proteostasis,
are
not
activated
but
rather
following
other,
unexpected
genetic
manipulations.
Our
results
comprise
cross-species
resource,
highlighting
networks
altered
by
pathophysiology
identifying
correspondences
preclinical
studies.
Scientific Data,
Journal Year:
2021,
Volume and Issue:
8(1)
Published: Oct. 15, 2021
Abstract
Mouse
models
of
human
diseases
are
invaluable
tools
for
studying
pathogenic
mechanisms
and
testing
interventions
therapeutics.
For
disorders
such
as
Alzheimer’s
disease
in
which
numerous
being
generated,
a
challenging
first
step
is
to
identify
the
most
appropriate
model
age
effectively
evaluate
new
therapeutic
approaches.
Here
we
conducted
detailed
phenotypic
characterization
5xFAD
on
congenic
C57BL/6
J
strain
background,
across
its
lifespan
–
including
seldomly
analyzed
18-month
old
time
point
provide
temporally
correlated
phenotyping
this
template
LOAD
they
generated.
This
comprehensive
analysis
included
quantification
plaque
burden,
Aβ
biochemical
levels,
neuropathology,
neurophysiological
measurements
behavioral
cognitive
assessments,
evaluation
microglia,
astrocytes,
neurons.
Analysis
transcriptional
changes
was
using
bulk-tissue
generated
RNA-seq
data
from
microdissected
cortices
hippocampi
function
aging,
can
be
explored
at
MODEL-AD
Explorer
AD
Knowledge
Portal.
deep-phenotyping
pipeline
identified
novel
aspects
age-related
pathology
model.
Translational Psychiatry,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: June 22, 2022
Abstract
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
disorder
leading
to
loss
of
cognitive
abilities
and
ultimately,
death.
With
no
cure
available,
limited
treatments
mostly
focus
on
symptom
management.
Identifying
early
changes
in
the
course
may
provide
new
therapeutic
targets
halt
or
reverse
progression.
Clinical
studies
have
shown
that
cortical
hippocampal
hyperactivity
are
feature
shared
by
patients
stages
disease,
progressing
hypoactivity
during
later
neurodegeneration.
The
exact
mechanisms
causing
neuronal
excitability
not
fully
characterized;
however,
animal
cell
models
provided
insights
into
some
factors
involved
this
phenotype.
In
review,
we
summarize
evidence
for
over
AD
onset
progression
molecular
underpinning
these
differences.
Specifically,
discuss
contributors
aberrant
excitability,
including
abnormal
levels
intracellular
Ca
2+
glutamate,
pathological
amyloid
β
(Aβ)
tau,
genetic
risk
factors,
APOE
,
impaired
inhibitory
interneuron
glial
function.
light
recent
research
indicating
hyperexcitability
could
be
predictive
marker
dysfunction,
further
argue
phenotype
leveraged
improve
diagnosis
treatment
AD,
present
potential
future
development.
Frontiers in Science,
Journal Year:
2023,
Volume and Issue:
1
Published: Feb. 28, 2023
Recent
advances
in
human
stem
cell-derived
brain
organoids
promise
to
replicate
critical
molecular
and
cellular
aspects
of
learning
memory
possibly
cognition
vitro
.
Coining
the
term
“organoid
intelligence”
(OI)
encompass
these
developments,
we
present
a
collaborative
program
implement
vision
multidisciplinary
field
OI.
This
aims
establish
OI
as
form
genuine
biological
computing
that
harnesses
using
scientific
bioengineering
an
ethically
responsible
manner.
Standardized,
3D,
myelinated
can
now
be
produced
with
high
cell
density
enriched
levels
glial
cells
gene
expression
for
learning.
Integrated
microfluidic
perfusion
systems
support
scalable
durable
culturing,
spatiotemporal
chemical
signaling.
Novel
3D
microelectrode
arrays
permit
high-resolution
electrophysiological
signaling
recording
explore
capacity
recapitulate
mechanisms
formation
and,
ultimately,
their
computational
potential.
Technologies
could
enable
novel
biocomputing
models
via
stimulus-response
training
organoid-computer
interfaces
are
development.
We
envisage
complex,
networked
whereby
connected
real-world
sensors
output
devices,
ultimately
each
other
sensory
organ
(e.g.
retinal
organoids),
trained
biofeedback,
big-data
warehousing,
machine
methods.
In
parallel,
emphasize
embedded
ethics
approach
analyze
ethical
raised
by
research
iterative,
manner
involving
all
relevant
stakeholders.
The
many
possible
applications
this
urge
strategic
development
discipline.
anticipate
OI-based
allow
faster
decision-making,
continuous
during
tasks,
greater
energy
data
efficiency.
Furthermore,
“intelligence-in-a-dish”
help
elucidate
pathophysiology
devastating
developmental
degenerative
diseases
(such
dementia),
potentially
aiding
identification
therapeutic
approaches
address
major
global
unmet
needs.
Brain,
Journal Year:
2019,
Volume and Issue:
142(4), P. 1077 - 1092
Published: Jan. 23, 2019
While
the
accumulation
and
aggregation
of
amyloid-β
tau
are
central
events
in
pathogenesis
Alzheimer's
disease,
there
is
increasing
evidence
that
cerebrovascular
pathology
also
abundant
disease
brains.
In
brain
capillaries,
endothelial
cells
connected
closely
with
one
another
through
transmembrane
tight
junction
proteins
forming
blood-brain
barrier.
Because
barrier
tightly
regulates
exchange
molecules
between
blood
maintains
homeostasis,
its
impairment
increasingly
recognized
as
a
critical
factor
contributing
to
pathogenesis.
However,
pathological
relationship
properties
progression
human
not
fully
understood.
this
study,
we
show
loss
cortical
common
event
correlated
synaptic
degeneration.
By
quantifying
amounts
major
proteins,
claudin-5
occludin,
12
regions
dissected
from
post-mortem
brains
normal
ageing
(n
=
10),
14)
patients
19),
found
they
were
selectively
decreased
areas
disease.
Cortical
association
Braak
neurofibrillary
tangle
stage.
There
was
negative
correlation
amount
insoluble
disease-related
particular
amyloid-β40,
areas.
addition,
these
positively
those
markers.
Thus,
associated
amyloid-β40
Importantly,
positive
markers,
synaptophysin,
present
independent
amyloid-β42
values,
suggesting
degeneration
present,
at
least
part,
proteins.
Collectively,
results
indicate
occurs
predominantly
neocortex
during
progression.
Further,
our
findings
provide
neuropathological
clue
how
may
contribute
both
synergistic
additive
manners
typical
pathologies.
Acta Neuropathologica,
Journal Year:
2021,
Volume and Issue:
143(2), P. 179 - 224
Published: Dec. 1, 2021
Abstract
In
neurological
diseases,
the
actions
of
microglia,
resident
myeloid
cells
CNS
parenchyma,
may
diverge
from,
or
intersect
with,
those
recruited
monocytes
to
drive
immune-mediated
pathology.
However,
defining
precise
roles
each
cell
type
has
historically
been
impeded
by
lack
discriminating
markers
and
experimental
systems
capable
accurately
identifying
them.
Our
ability
distinguish
microglia
from
in
neuroinflammation
advanced
with
single-cell
technologies,
new
drugs
that
identify
deplete
them,
respectively.
Nevertheless,
focus
individual
studies
on
particular
types,
diseases
approaches
limited
our
connect
phenotype
function
more
widely
across
diverse
pathologies.
Here,
we
critically
review,
tabulate
integrate
disease-specific
functions
immune
profiles
provide
a
comprehensive
atlas
responses
viral
encephalitis,
demyelination,
neurodegeneration
ischemic
injury.
emphasizing
differential
severe
neuroinflammatory
disease
inflammatory
pathways
common
equally
incapacitating
less
inflammation.
We
examine
these
findings
context
human
highlight
benefits
inherent
limitations
animal
models
impede
facilitate
clinical
translation.
This
enables
us
contrasting,
non-redundant
often
opposing
could
be
targeted
therapeutically.